Anoro ellipta and Bladder cancer - a phase IV clinical study of FDA data

Summary:

Bladder cancer is reported as a side effect among people who take Anoro ellipta (umeclidinium bromide; vilanterol trifenatate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Proair Hfa, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Bladder cancer when taking Anoro ellipta. It is created by eHealthMe based on reports of 16,408 people who have side effects when taking Anoro ellipta from the FDA, and is updated regularly.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

What is Bladder cancer?

Bladder cancer is found to be associated with 725 drugs and 1,029 conditions by eHealthMe. Check the latest studies of Bladder cancer.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

16,408 people reported to have side effects when taking Anoro ellipta.
Among them, 17 people (0.1%) have Bladder cancer.

Could Anoro ellipta cause Bladder cancer?

Among these 17 people:

How long have people been on Anoro ellipta when they have Bladder cancer? *

What is the gender of people who have Bladder cancer when taking Anoro ellipta? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Bladder cancer when taking Anoro ellipta? *

What are other drugs people take besides Anoro ellipta? *

What are other side effects people have besides Bladder cancer? *

Gastric Ulcer (stomach ulcer): 3 people, 17.65%
Stress And Anxiety: 3 people, 17.65%
Fatigue (feeling of tiredness): 3 people, 17.65%
Fall: 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 2 people, 11.76%
Urination - Painful: 2 people, 11.76%
Calculus Bladder (bladder stone): 2 people, 11.76%
Pain: 2 people, 11.76%
Weight Increased: 1 person, 5.88%
Groin Pain: 1 person, 5.88%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 41.18%
Immunodeficiency Common Variable: 4 people, 23.53%
Prostate Cancer: 2 people, 11.76%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 5.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Anoro ellipta and have Bladder cancer?

- Check whether Bladder cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anoro ellipta:

Anoro ellipta (16,515 reports)

Bladder cancer treatments and more:

Bladder cancer (75,593 reports)

How severe was Bladder cancer and when was it recovered:

Bladder cancer in Anoro ellipta

Expand to all the drugs that have ingredients of umeclidinium bromide; vilanterol trifenatate:

Bladder cancer and drugs with ingredients of umeclidinium bromide; vilanterol trifenatate (17 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bladder cancer:

Bladder cancer (725 drugs)

Browse all the conditions that are associated with Bladder cancer:

Bladder cancer (1,029 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on umeclidinium bromide; vilanterol trifenatate (the active ingredients of Anoro ellipta) and Anoro ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.